Lucis raises $20M Series A for AI health platform
Rapid funding for AI health: see how Lucis uses biomarkers and AI for personalized preventive care.
30-Second TL;DR
What Changed
Raised $20M Series A led by Singular.
Why It Matters
Lucis represents the growing trend of 'AI-first' preventive healthcare, where multimodal data (biomarkers + app usage) is used to create personalized health trajectories.
What To Do Next
Explore how multimodal health data integration can improve the accuracy of your AI health models by incorporating clinical-grade biomarkers.
Key Points
- •Raised $20M Series A led by Singular.
- •Follows an $8.5M seed round just four months prior.
- •Combines clinical blood biomarker data with AI analysis.
- •Investors include General Catalyst and Y Combinator.
Weekly AI Recap
Read this week's curated digest of top AI events →
Related Updates
AI-curated news aggregator. All content rights belong to original publishers.
Original source: The Next Web (TNW) ↗
This is a summary, not the original. Read the source, or get the weekly briefing.
The weekly digest
One email a week. Unsubscribe anytime.